CW20135

General

Cell Line

hPSCreg name CIRMi17L-A
Cite as:
CIRMi17L-A (RRID:CVCL_DJ33)
Alternative name(s)
CW20135
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
CIRMi18J-A
(CW20184)
Donor diseases:
Autism Spectrum Disorder
CIRMi18M-A
(CW20188)
Donor diseases:
Autism Spectrum Disorder
CIRMi18N-A
(CW20192)
Donor diseases:
Autism Spectrum Disorder
CIRMi18S-A
(CW20201)
Donor diseases:
Autism Spectrum Disorder
CIRMi18T-A
(CW20202)
Donor diseases:
Autism Spectrum Disorder
CIRMi18U-A
(CW20203)
Donor diseases:
Autism Spectrum Disorder
CIRMi18V-A
(CW20204)
Donor diseases:
Autism Spectrum Disorder
CIRMi18W-A
(CW20206)
Donor diseases:
Autism Spectrum Disorder
CIRMi18X-A
(CW20207)
Donor diseases:
Autism Spectrum Disorder
CIRMi19A-A
(CW20212)
Donor diseases:
Autism Spectrum Disorder
CIRMi19E-A
(CW20225)
Donor diseases:
Autism Spectrum Disorder
CIRMi19G-A
(CW20231)
Donor diseases:
Autism Spectrum Disorder
CIRMi19N-A
(CW20245)
Donor diseases:
Autism Spectrum Disorder
CIRMi19O-A
(CW20249)
Donor diseases:
Autism Spectrum Disorder
CIRMi19Q-A
(CW20273)
Donor diseases:
Autism Spectrum Disorder
CIRMi19R-A
(CW20277)
Donor diseases:
Autism Spectrum Disorder
CIRMi19S-A
(CW20278)
Donor diseases:
Autism Spectrum Disorder
CIRMi13Z-A
(CW20006)
Donor diseases:
Autism Spectrum Disorder
CIRMi14A-A
(CW20008)
Donor diseases:
Autism Spectrum Disorder
CIRMi14D-A
(CW20015)
Donor diseases:
Autism Spectrum Disorder
CIRMi14J-A
(CW20026)
Donor diseases:
Autism Spectrum Disorder
CIRMi14M-A
(CW20030)
Donor diseases:
Autism Spectrum Disorder
CIRMi14R-A
(CW20035)
Donor diseases:
Autism Spectrum Disorder
CIRMi14S-A
(CW20039)
Donor diseases:
Autism Spectrum Disorder
CIRMi14W-A
(CW20044)
Donor diseases:
Autism Spectrum Disorder
CIRMi15B-A
(CW20050)
Donor diseases:
Autism Spectrum Disorder
CIRMi15E-A
(CW20053)
Donor diseases:
Autism Spectrum Disorder
CIRMi15G-A
(CW20055)
Donor diseases:
Autism Spectrum Disorder
CIRMi15L-A
(CW20062)
Donor diseases:
Autism Spectrum Disorder
CIRMi15N-A
(CW20065)
Donor diseases:
Autism Spectrum Disorder
CIRMi15Q-A
(CW20070)
Donor diseases:
Autism Spectrum Disorder
CIRMi15U-A
(CW20076)
Donor diseases:
Autism Spectrum Disorder
CIRMi15Z-A
(CW20081)
Donor diseases:
Autism Spectrum Disorder
CIRMi16A-A
(CW20083)
Donor diseases:
Autism Spectrum Disorder
CIRMi16G-A
(CW20092)
Donor diseases:
Autism Spectrum Disorder
CIRMi16I-A
(CW20095)
Donor diseases:
Autism Spectrum Disorder
CIRMi16L-A
(CW20100)
Donor diseases:
Autism Spectrum Disorder
CIRMi16M-A
(CW20101)
Donor diseases:
Autism Spectrum Disorder
CIRMi17A-A
(CW20121)
Donor diseases:
Autism Spectrum Disorder
CIRMi17D-A
(CW20124)
Donor diseases:
Autism Spectrum Disorder
CIRMi17P-A
(CW20140)
Donor diseases:
Autism Spectrum Disorder
CIRMi17Q-A
(CW20141)
Donor diseases:
Autism Spectrum Disorder
CIRMi17R-A
(CW20142)
Donor diseases:
Autism Spectrum Disorder
CIRMi17V-A
(CW20150)
Donor diseases:
Autism Spectrum Disorder
CIRMi17W-A
(CW20151)
Donor diseases:
Autism Spectrum Disorder
CIRMi17Y-A
(CW20153)
Donor diseases:
Autism Spectrum Disorder
CIRMi17Z-A
(CW20156)
Donor diseases:
Autism Spectrum Disorder
CIRMi18C-A
(CW20166)
Donor diseases:
Autism Spectrum Disorder
CIRMi18G-A
(CW20179)
Donor diseases:
Autism Spectrum Disorder
CIRMi18H-A
(CW20181)
Donor diseases:
Autism Spectrum Disorder
Last update 13th March 2024
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator California Institute for Regenerative Medicine (CIRM)
Owner California Institute for Regenerative Medicine (CIRM)
Distributors
Derivation country United States

External Databases

BioSamples SAMEA115402204
Cellosaurus CVCL_DJ33
Wikidata Q54815226

General Information

* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: allowed

Donor Information

General Donor Information

Sex male
Age of donor (at collection) 10-14

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
AUTISM SPECTRUM DISORDER; ASD
Synonyms
  • Pervasive Developmental Disorders
  • Autism Spectrum Disorder

External Databases (Donor)

BioSamples SAMEA115402205

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? No
Please provide contact information of the holder of the original Donor Information Sheet. info@cirm.ca.gov
Do you (Depositor/Provider) hold the original Donor Consent Form? No
If you do not hold the Donor Consent Form, do you know who does? Yes
Please provide the contact information info@cirm.ca.gov
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. pseudonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
How may genetic information associated with the cell line be accessed? Controlled Access
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? Stanford University
Approval number 27290
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells? Yes
Name of accrediting authority involved? Stanford University
Approval number 27290
Is there an MTA available for the cell line? Yes

hIPSC Derivation

General

Source cell type
A cell found predominately in the blood.
Age of donor (at collection) 10-14

Reprogramming method

Vector type Non-integrating
Vector Episomal
Is reprogramming vector detectable?
No

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Medium Essential 8™

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
POU5F1 (OCT-4)
Yes
NANOG
Yes
LIN28
Yes
Undifferentiated cells were analyzed by proprietary assays approved by California Institute of Regenerative Medicine (CIRM) as described in the attached publication. Pluripotency of established iPSC cultures were tested by qPCR on bulk samples using 48 genes including standard pluripotency genes (listed above). Samples were assigned a passing score after analysis with a non-supervised classifier based on an appropriate sample set. (Novak, T. 2015. Drug Discovery World pp. 47-53.)
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
Mesoderm
Ont Id: UBERON_0000926
Ectoderm
Ont Id: UBERON_0000924

Microbiology / Virus Screening

HIV 1 Negative
HIV 2 Negative
Hepatitis B Negative
Hepatitis C Negative
Mycoplasma Negative

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
Normal

Other Genotyping (Cell Line)